Noveris Health Sciences 

€0
0
+€0+0% Hari ini

Statistik

Tertinggi hari ini
-
Terendah hari ini
-
Tertinggi 52M
-
Terendah 52M
-
Volume
-
Vol. rata2
-
Kap. pasar
0
Rasio P/E
-
Imbal hasil dividen
-
Dividen
-

Orang juga mengikuti

Daftar ini didasarkan pada daftar pantauan pengguna Stock Events yang mengikuti 0NF1.MU. Ini bukan rekomendasi investasi.

Pesaing

Daftar ini adalah analisis berdasarkan peristiwa pasar terbaru. Ini bukan rekomendasi investasi.

Tentang

Mydecine Innovations Group Inc., a biotechnology company, engages in the development and commercialization of psilocybin products for treating mental health problems. The company primarily focuses on treating smoking cessation. Its lead product drug candidates include MYCO-001, MYCO-002, MYCO003, and MYCO-004. Mydecine Innovations Group Inc. has a partnership with Applied Pharmaceutical Innovation for pharmaceutical drug discovery, research, and development on empathogenic and entactogenic compounds. The company was formerly known as NewLeaf Brands Inc. and changed its name to Mydecine Innovations Group Inc. in June 2020. Mydecine Innovations Group Inc. was incorporated in 2013 and is headquartered in Vancouver, Canada.
Show more...
CEO
Mr. David Joshua Bartch
Karyawan
3
Negara
Kanada
ISIN
CA66990B1085

Pencatatan

0 Comments

Bagikan pendapatmu

FAQ

Apa simbol saham Noveris Health Sciences?
Tergantung pada bursa, simbol saham dapat berbeda. Misalnya, di bursa , saham Noveris Health Sciences diperdagangkan dengan simbol 0NF1.MU.
Berapa jumlah karyawan Noveris Health Sciences?
Per April 12, 2026, perusahaan memiliki 3 karyawan.
Noveris Health Sciences berada di sektor apa?
Noveris Health Sciences beroperasi di sektor Kesehatan & Kebugaran.
Kapan Noveris Health Sciences menyelesaikan split saham?
Noveris Health Sciences belum melakukan split saham baru-baru ini.
Di mana kantor pusat Noveris Health Sciences?
Kantor pusat Noveris Health Sciences berlokasi di Vancouver, Kanada.